Datum Källa Rubrik Typ Alternativ
2020-05-20 Sedana Medical Sedana Medical: Utnyttjande av teckningsoptioner i incitamentsprogram 2017/21 Pressreleaser Ladda ner | Visa Stäng
2020-05-19 Sedana Medical Bulletin from the Annual General Meeting in Sedana Medical Pressreleaser Ladda ner | Visa Stäng
Pressreleaser | 19 May 2020 | Sedana Medical

Bulletin from the Annual General Meeting in Sedana Medical

Adoption of the profit and loss statement and the balance sheet, the consolidated profit and loss statement and the consolidated balance sheet as well as resolution regarding allocation of profits and discharge from liability

The general meeting adopted the profit and loss statement and the balance sheet as well as the consolidated profit and loss statement and the consolidated balance sheet for the financial year 2019 and resolved, in accordance with the board of directors’ proposal and the auditor’s recommendation, that the accumulated profits shall be carried forward.

The general meeting resolved to discharge the members of the board of directors and the CEO from liability.

Determination of fees payable for the members of the board of directors and the auditor

The general meeting resolved that fees payable to the members of the board of directors shall be payed with a total amount of SEK 1,000,000, whereby SEK 400,000 shall be payed to the chairman of the board, SEK 100,000 shall be payed to each of the board members Sten Gibeck, Bengt Julander and Ola Magnusson (who are also major shareholders in the company), and SEK 150,000 shall be payed to each of the other board members elected by the general meeting. The general meeting further resolved that fees payable for work in the audit committee of the board of directors, which is under establishment, shall be payed with SEK 25,000 to the chairman of the committee and with SEK 12,500 to each of the other members of the committee, and that fees payable to the auditor shall be payed in accordance with approved invoices within the frames of the quote.

Election of board members and auditor

The general meeting resolved to re-elect Thomas Eklund, Sten Gibeck, Bengt Julander, Ola Magnusson and Eva Walde and to newly elect Christoffer Rosenblad as ordinary board members in Sedana Medical for the period until the end of the next annual general meeting. Thomas Eklund was also re-elected as chairman of the board of directors.

The general meeting resolved to elect Öhrlings PricewaterhouseCoopers AB as new auditor for the period until the end of the next annual general meeting, with the chartered accountant Leonard Daun as principal auditor.

Resolution on authorisation for the board of directors to issue new shares

The general meeting resolved to authorise the board of directors to, at one or more occasions during the period until the next annual general meeting, with or without deviation from the shareholders’ preferential rights, resolve on new share issues. The number of shares issued by exercise of the authorisation may not exceed 10% of the total number of shares outstanding in the Company as of the date of the annual general meeting. A new issue may be made with or without stipulations regarding non-cash consideration, set-off or other conditions referred to in Chapter 13, Section 5, first paragraph, item 6 of the Swedish Companies Act (Sw. aktiebolagslagen (2005:551)). The objective of the authorisation is to provide the board of directors with flexibility in its work to ensure that the company can procure capital for the financing of the operations in an appropriate manner, to enable business or company acquisitions and to enable a broadening of the company’s shareholder base.

Resolution on amendment of the articles of association

The general meeting resolved to change § 1, § 6, § 7 and § 9 of the Company’s articles of association.

The amendment of § 1 is made due to changes in the Swedish Companies Act (Sw. aktiebolagslagen (2005:551)). The amendment of § 6 removes the possibility to have deputy directors. The amendment of § 7 is an editorial clarification and is made by reason of to the nomination committee’s proposal that a registered accounting firm is appointed as auditor. The amendments in § 9 is made due to future changes of certain rules regarding record dates in the Swedish Companies Act (Sw. aktiebolagslagen (2005:551)).

Resolution on incentive programme 2020/2023 for co-workers by way of a directed issue of warrants to a subsidiary to be subsequently transferred to participants

The general meeting resolved to adopt incentive programme 2020/2023 for co-workers, including a directed issue of not more than 325,000 warrants series 2020/2023 to the Company’s subsidiary Sedana Medical Incentive AB to be subsequently transferred to the participants in the incentive programme. The objectives of the incentive programme are to establish conditions to recruit and maintain qualified personnel in the group and to increase the motivation of the co-workers of the group and to stimulate an increased interest for the Company’s business and earnings. Assuming full exercise of all warrants of series 2020/2023, the Company’s share capital will increase by SEK 32,500, and the number of shares and votes in the Company will increase by 325,000, equivalent to a dilution effect of approximately 1.39 per cent of the total number of shares and votes in the Company (based on the current number of shares and votes, without consideration of outstanding warrants).

Resolution on incentive programme 2020/2024 for current and new co-workers by way of a directed issue of warrants to a subsidiary to be subsequently transferred to participants

The general meeting resolved to adopt incentive programme 2020/2024 for current and new co-workers, including a directed issue of not more than 360,000 warrants of series 2020/2024 to the Company’s subsidiary Sedana Medical Incentive AB to be subsequently transferred to the participants in the incentive programme. The incentive programme is intended for both current co-workers as well as co-workers starting their employment or assignment in the Company’s group during the period 21 May 2020-31 January 2021. The objectives of the incentive programme are the same as for incentive programme 2020/2023. Assuming full exercise of all warrants of series 2020/2024, the Company’s share capital will increase with SEK 36,000, and the number of shares and votes in the Company will increase with 360,000, equivalent to a dilution effect of approximately 1.54 per cent of the total number of shares and votes in the Company (based on the current number of shares and votes, without consideration of outstanding warrants).

For additional information, please contact:
Thomas Eklund, Chairman of the Board
Mobile: +46 70 824 20 25
E-mail: thomas.eklund@investorab.com

Sedana Medical is listed on Nasdaq First North Growth Market in Stockholm.
The company’s Certified Adviser is Erik Penser Bank, +46 8 463 83 00, certifiedadviser@penser.se.

The information was released for public disclosure, through the agency of the contact person above, on May 19, 2020 at 5:00 p.m. (CEST).

About Sedana Medical

Sedana Medical AB (publ) has developed and sells the medical device AnaConDa, for the administration of volatile anaesthetics to mechanically ventilated patients. A major pivotal study is currently ongoing to obtain market approval in Europe for inhaled sedation in intensive care units with the pharmaceutical IsoConDa® (isoflurane). The company expects the registration of IsoConDa in Europe to take place during the second half of 2021. Three years thereafter Sedana Medical expects sales of SEK 500 million in Europe and an EBITDA margin of about 40 percent.

The market for Sedana Medical’s sedation therapy of AnaConDa and IsoConDa consists primarily of sedation of mechanically ventilated intensive care patients. Today, these patients are sedated intravenously which leads to several challenges for both patients and care givers. Challenges that are solved by inhaled sedation. Based on an estimate of seven to eight million patients being sedated in intensive care due to mechanical ventilation globally, on average three to four days, Sedana Medical estimates the total market potential to SEK 20-30 billion, evenly distributed between the US, Europe and Asia. The company has initiated a process to obtain market approval in the US in 2024. Registration activities are also initiated in other markets outside the EU.

Sedana Medical has direct sales in the Nordic countries, Germany, Benelux, France, Great Britain and Spain as well as external distributors in parts of the rest of Europe, Australia, Canada, China, India, Israel, Japan, Mexico and South Korea. The company was founded in 2005 and is headquartered in Stockholm, Sweden, with medical device development in Ireland.

2020-05-19 Sedana Medical Kommuniké från årsstämma i Sedana Medical Pressreleaser Ladda ner | Visa Stäng
2020-05-15 Sedana Medical Sedana Medical: Första patienten inkluderad i SESAR-studien om lungprotektion Pressreleaser Ladda ner | Visa Stäng
2020-05-12 Sedana Medical Sedana Medical stöder multinationell inhalationssederingsstudie i covid-19 ARDS Pressreleaser Ladda ner | Visa Stäng
2020-05-07 Sedana Medical Sedana Medical AB (publ), interim report Q1, 2020 Rapporter Ladda ner | Visa Stäng
2020-05-07 Sedana Medical Sedana Medical AB (publ), kvartalsrapport 1, 2020 Rapporter Ladda ner | Visa Stäng
2020-04-22 Sedana Medical Sedana Medicals årsredovisning för 2019 offentliggjord Rapporter Ladda ner | Visa Stäng
2020-04-22 Sedana Medical Sedana Medical publishes its Annual Report for 2019 Pressreleaser Ladda ner | Visa Stäng
2020-04-16 Sedana Medical Notice of Annual General Meeting in Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2020-04-16 Sedana Medical Kallelse till årsstämma i Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2020-04-09 Sedana Medical The nomination committee's resolution proposals for election of board members etc. at the annual general meeting in Sedana Medical Pressreleaser Ladda ner | Visa Stäng
2020-04-09 Sedana Medical Valberedningens förslag till val av styrelseledamöter m.m. inför årsstämman i Sedana Medical Pressreleaser Ladda ner | Visa Stäng
2020-04-06 Sedana Medical Sedana Medical's sales increase around 90 percent Pressreleaser Ladda ner | Visa Stäng
2020-04-06 Sedana Medical Sedana Medical ökar omsättningen cirka 90 procent Pressreleaser Ladda ner | Visa Stäng
2020-03-30 Sedana Medical Sedana Medical ser ökad efterfrågan och håller tidplanen Pressreleaser Ladda ner | Visa Stäng
2020-03-30 Sedana Medical Sedana Medical sees increased demand and keeps time schedule Pressreleaser Ladda ner | Visa Stäng
2020-03-20 Sedana Medical Sedana Medical: AnaConDa e-learning released to meet increased inquiries related to COVID-19 Pressreleaser Ladda ner | Visa Stäng
2020-03-05 Sedana Medical Sedana Medical AB (publ), Year-end report, 2019 Pressreleaser Ladda ner | Visa Stäng
2020-03-05 Sedana Medical Sedana Medical AB (publ), bokslutskommuniké, 2019 Pressreleaser Ladda ner | Visa Stäng
2020-02-27 Sedana Medical Sedana Medical donerar AnaConDa till sjukhus i Wuhan, Kina Pressreleaser Ladda ner | Visa Stäng
2020-02-27 Sedana Medical Sedana Medical donates AnaConDa to hospitals in Wuhan, China Pressreleaser Ladda ner | Visa Stäng
2020-02-05 Sedana Medical Sedana Medical etablerar försäljningsorganisation i Benelux Pressreleaser Ladda ner | Visa Stäng
2020-02-05 Sedana Medical Sedana Medical establishes sales organization in Benelux Pressreleaser Ladda ner | Visa Stäng
2020-01-28 Sedana Medical Sedana Medical erhåller godkännande för AnaConDa i Mexico Pressreleaser Ladda ner | Visa Stäng
2020-01-28 Sedana Medical Sedana Medical receives approval for AnaConDa in Mexico Pressreleaser Ladda ner | Visa Stäng
2020-01-20 Sedana Medical Sedana Medical's CEO divests shares - remains committed and long-term shareholder Pressreleaser Ladda ner | Visa Stäng
2020-01-20 Sedana Medical Sedana Medicals VD avyttrar aktier - kvarstår som dedikerad långsiktig ägare Pressreleaser Ladda ner | Visa Stäng
2020-01-13 Sedana Medical Sista patienten inkluderad i Sedana Medicals registreringsgrundande IsoConDa-studie Pressreleaser Ladda ner | Visa Stäng
2019-12-04 Sedana Medical Sedana Medical stöder sederingsstudie med isofluran för minskning av delirium Pressreleaser Ladda ner | Visa Stäng
2019-12-04 Sedana Medical Sedana Medical supports isoflurane sedation study for reduction of delirium Pressreleaser Ladda ner | Visa Stäng
2019-11-13 Sedana Medical Sedana Medical AB (publ), Interim report Q3, 2019 Rapporter Ladda ner | Visa Stäng
2019-11-13 Sedana Medical Sedana Medical AB (publ), kvartalsrapport 3, 2019 Rapporter Ladda ner | Visa Stäng
2019-11-12 Sedana Medical Sedana Medicals styrelseledamot Michael Ryan avgår Pressreleaser Ladda ner | Visa Stäng
2019-11-12 Sedana Medical Sedana Medical's board member Michael Ryan resigns Pressreleaser Ladda ner | Visa Stäng
2019-11-08 Sedana Medical Sedana Medical justerar och förtydligar sina långsiktiga finansiella mål Pressreleaser Ladda ner | Visa Stäng
2019-11-08 Sedana Medical Sedana Medical adjusts and clarifies its long-term financial targets Pressreleaser Ladda ner | Visa Stäng
2019-10-17 Sedana Medical Sedana Medicals valberedning utsedd Pressreleaser Ladda ner | Visa Stäng
2019-10-16 Sedana Medical Sedana Medical delfinansierar AnaConDa-studie om lungprotektion Pressreleaser Ladda ner | Visa Stäng
2019-10-09 Sedana Medical Sedana Medical AB (publ) genomför en riktad nyemission om 2 896 000 aktier och tillförs 375 miljoner SEK Pressreleaser Ladda ner | Visa Stäng
2019-10-09 Sedana Medical Sedana Medical AB (publ) has completed a directed new share issue of 2,896,000 shares, raising proceeds of SEK 375 million Pressreleaser Ladda ner | Visa Stäng
2019-10-09 Sedana Medical Sedana Medical AB (publ) prepares for listing on the Nasdaq Stockholm main market Pressreleaser Ladda ner | Visa Stäng
2019-10-09 Sedana Medical Sedana Medical AB (publ) intends to undertake a directed new share issue Pressreleaser Ladda ner | Visa Stäng
2019-10-09 Sedana Medical Sedana Medical AB (publ) avser genomföra en riktad nyemission av aktier Pressreleaser Ladda ner | Visa Stäng
2019-10-09 Sedana Medical Sedana Medical AB (publ) förbereder notering på Nasdaq Stockholms huvudlista Pressreleaser Ladda ner | Visa Stäng
2019-09-30 Sedana Medical Sedana Medicals AnaConDa godkänd för användning på barn Pressreleaser Ladda ner | Visa Stäng
2019-08-22 Sedana Medical Sedana Medical AB (publ), Interim report Q2, 2019 Rapporter Ladda ner | Visa Stäng
2019-08-22 Sedana Medical Sedana Medical AB (publ), kvartalsrapport 2, 2019 Rapporter Ladda ner | Visa Stäng
2019-08-15 Sedana Medical Sedana Medical enters India - signs Indian distributor Pressreleaser Ladda ner | Visa Stäng
2019-08-15 Sedana Medical Sedana Medical går in i Indien - sluter avtal med indisk distributör Pressreleaser Ladda ner | Visa Stäng
2019-05-28 Sedana Medical Kommuniké från årsstämma i Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2019-04-25 Sedana Medical Sedana Medicals årsredovisning för 2018 offentliggjord Pressreleaser Ladda ner | Visa Stäng
2019-03-12 Sedana Medical Sedana Medical bokslutskommuniké, januari - december 2018. - Stark tillväxt och positiv utveckling av registreringsarbetet Rapporter Ladda ner | Visa Stäng
2019-03-12 Sedana Medical Sedana Medical Year-end Report, January - December 2018. - Strong growth and positive registration work development Rapporter Ladda ner | Visa Stäng
2019-03-08 Sedana Medical Sedana Medical: Positive interim analysis in pivotal IsoConDa phase III study Pressreleaser Ladda ner | Visa Stäng
2019-03-08 Sedana Medical Sedana Medical: Positiv interimanalys av IsoConDa fas III registreringsstudie Pressreleaser Ladda ner | Visa Stäng
2019-03-07 Sedana Medical Tidigarelagt datum för release av Sedana Medicals bokslutskommuniké 2018 Pressreleaser Ladda ner | Visa Stäng
2019-02-12 Sedana Medical Sedana Medical får klartecken för pediatrisk studie  - Milstolpe på vägen mot marknadsexklusivitet Pressreleaser Ladda ner | Visa Stäng
2019-02-12 Sedana Medical Sedana Medical receives go-ahead for pediatric study  - Milestone on the road to market exclusivity Pressreleaser Ladda ner | Visa Stäng
2018-12-03 Sedana Medical Rättelse av tidigare utskickad pressrelease Sedana Medical AB (publ), Sedana Medicals valberedning utsedd Pressreleaser Ladda ner | Visa Stäng
2018-12-03 Sedana Medical Amendment of previously announced press release Sedana Medical AB (publ), Sedana Medical's nomination committee appointed Pressreleaser Ladda ner | Visa Stäng
2018-12-03 Sedana Medical Sedana Medical's nomination committee appointed Pressreleaser Ladda ner | Visa Stäng
2018-12-03 Sedana Medical Sedana Medicals valberedning utsedd Pressreleaser Ladda ner | Visa Stäng
2018-11-22 Sedana Medical Sedana Medical AB (publ), Interim report Q3, 2018 Rapporter Ladda ner | Visa Stäng
2018-11-22 Sedana Medical Sedana Medical AB (publ), Kvartalsrapport 3, 2018 Rapporter Ladda ner | Visa Stäng
2018-11-14 Sedana Medical Sedana Medical visar betydande hälsoekonomiska fördelar med AnaConDa Pressreleaser Ladda ner | Visa Stäng
2018-11-02 Sedana Medical Sedana Medical receives approval for AnaConDa in Japan Pressreleaser Ladda ner | Visa Stäng
2018-11-02 Sedana Medical Sedana Medical erhåller godkännande för AnaConDa i Japan Pressreleaser Ladda ner | Visa Stäng
2018-09-27 Sedana Medical Sedana Medical AB (publ) - Första direktförsäljningen av AnaConDa i Storbritannien. Pressreleaser Ladda ner | Visa Stäng
2018-09-20 Sedana Medical Genomförd försäljning av aktier i Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2018-09-20 Sedana Medical Completed sale of shares in Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2018-08-30 Sedana Medical Rättelse av tidigare utskickat pressmeddelande Sedana Medical AB (publ), Kvartalsrapport 2, 2018 Rapporter Ladda ner | Visa Stäng
2018-08-30 Sedana Medical Correction of previously announced press release Sedana Medical AB (publ), Interim report Q2, 2018 Rapporter Ladda ner | Visa Stäng
2018-08-30 Sedana Medical Sedana Medical AB (publ), Interim report Q2, 2018 Rapporter Ladda ner | Visa Stäng
2018-08-30 Sedana Medical Sedana Medical AB (publ), Kvartalsrapport 2, 2018 Rapporter Ladda ner | Visa Stäng
2018-08-22 Sedana Medical Sedana Medical bjuder in till webbsänd telefonpresentation av bolagets delårsrapport för det andra kvartalet 2018 Pressreleaser Ladda ner | Visa Stäng
2018-07-26 Sedana Medical Sedana Medical AB (publ) återupptar sin fas 3-studie IsoConDa med full patientrekryteringstakt. Pressreleaser Ladda ner | Visa Stäng
2018-07-26 Sedana Medical Sedana Medical AB (publ) resumes pivotal phase 3-study IsoConDa with full patient recruitment rate. Pressreleaser Ladda ner | Visa Stäng
2018-06-18 Sedana Medical Sedana Medical AB (publ) rekryterar Global Marketing Director. Pressreleaser Ladda ner | Visa Stäng
2018-06-18 Sedana Medical Sedana Medical AB (publ) recruits Global Marketing Director Pressreleaser Ladda ner | Visa Stäng
2018-06-05 Sedana Medical Sedana Medical AB (publ) has completed a directed new share issue of approximately SEK 112 million directed to institutional investors Pressreleaser Ladda ner | Visa Stäng
2018-06-05 Sedana Medical Sedana Medical AB (publ) har genomfört en riktad nyemission om cirka 112 miljoner kronor riktad till institutionella investerare Pressreleaser Ladda ner | Visa Stäng
2018-06-04 Sedana Medical Sedana Medical AB (publ) avser genomföra en riktad nyemission av aktier Pressreleaser Ladda ner | Visa Stäng
2018-06-04 Sedana Medical Sedana Medical AB (publ) intends to undertake a directed new share issue Pressreleaser Ladda ner | Visa Stäng
2018-05-22 Sedana Medical Kommuniké från årsstämma i Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2018-05-22 Sedana Medical Bulletin from annual general meeting in Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2018-05-22 Sedana Medical Sedana Medical AB (publ), Delårsrapport Kvartal 1, 2018. Rekordstark försäljning och ökad marknadsnärvaro Rapporter Ladda ner | Visa Stäng
2018-04-25 Sedana Medical Sedana Medicals årsredovisning för 2017 offentliggjord Rapporter Ladda ner | Visa Stäng
2018-04-12 Sedana Medical Sedana Medical AB (publ) redovisar rekordstor försäljningsökning under första kvartalet 2018. Pressreleaser Ladda ner | Visa Stäng
2018-04-11 Sedana Medical Sedana Medical AB (publ) bjuder in till telefonkonferensmöte baserat på uppdaterad tidsplan för IsoConDa studien. Pressreleaser Ladda ner | Visa Stäng
2018-04-10 Sedana Medical Sedana Medical AB (publ) uppdaterar tidsplanen för IsoConDa studien. Pressreleaser Ladda ner | Visa Stäng
2018-04-09 Sedana Medical Kallelse till årsstämma i Sedana Medical AB (publ) Pressreleaser Ladda ner | Visa Stäng
2018-03-27 Sedana Medical Sedana Medical AB (publ), Bokslutskommuniké 2017: Stark försäljningsutveckling och ökat intresse för AnaConDa och inhalationssedering. Rapporter Ladda ner | Visa Stäng
2018-03-20 Sedana Medical Sedana Medical AB:s (publ) meddelar valberednings förslag till ny styrelse inför årsstämman 2018 Pressreleaser Ladda ner | Visa Stäng
2018-03-01 Sedana Medical Sedana Medical AB (publ) startar egen försäljningsverksamhet i Norge och Danmark. Pressreleaser Ladda ner | Visa Stäng
2017-12-18 Sedana Medical Sedana Medical AB (publ) byter Certified Adviser från Pareto Securities AB till Erik Penser Bank. Pressreleaser Ladda ner | Visa Stäng
2017-11-30 Sedana Medical Sedana Medical AB (publ), Delårsrapport 3, juli-september 2017: Fortsatt stark försäljningsutveckling och registreringsstudien för Europa enligt plan Rapporter Ladda ner | Visa Stäng
2017-11-23 Sedana Medical Sedana Medical AB (publ) ansöker om registrering av AnaConDa i Japan Pressreleaser Ladda ner | Visa Stäng
2017-10-04 Sedana Medical Sedana Medical AB (publ) rekryterar Peter Sackey som Medicinsk Chef, Chief Medical Officer (CMO). Pressreleaser Ladda ner | Visa Stäng
2017-08-31 Sedana Medical Sedana Medical AB (publ), Delårsrapport kvartal 2, januari-juni 2017 Rapporter Ladda ner | Visa Stäng
2017-08-31 Sedana Medical Sedana Medical AB (publ), Interim Report, Q2, January-June 2017 Rapporter Ladda ner | Visa Stäng
2017-07-07 Sedana Medical Exercise of the overallotment option Pressreleaser Ladda ner | Visa Stäng
2017-07-07 Sedana Medical Utnyttjande av övertilldelningsoptionen Pressreleaser Ladda ner | Visa Stäng
2017-07-06 Sedana Medical Sedana Medical har uppnått en ny viktig milstolpe - Den första behandlade patienten med AnaConDa i Asien. Pressreleaser Ladda ner | Visa Stäng
2017-07-06 Sedana Medical Sedana Medical reaches an important milestone - The first patient in Asia is treated with AnaConDa. Pressreleaser Ladda ner | Visa Stäng
2017-06-29 Sedana Medical Sedana Medical AB (publ) in final deal with Teleflex Medical Incorporation Pressreleaser Ladda ner | Visa Stäng
2017-06-29 Sedana Medical Sedana Medical AB (publ) i slutlig uppgörelse med Teleflex Medical Incorporation Pressreleaser Ladda ner | Visa Stäng

Kommande händelser

22 May 2018 | Årsstämma 2017
22 May 2018 | Kvartalsrapport 2018-Q1
23 May 2018 | Årligutdelning
30 Aug 2018 | Kvartalsrapport 2018-Q2
22 Nov 2018 | Kvartalsrapport 2018-Q3
21 Mar 2019 | Bokslutskommuniké 2018
25 Apr 2019 | Kvartalsrapport 2019-Q1
8 May 2019 | Kvartalsrapport 2019-Q1
28 May 2019 | Årsstämma 2018
29 May 2019 | Årligutdelning
22 Aug 2019 | Kvartalsrapport 2019-Q2
5 Mar 2020 | Bokslutskommuniké 2019
7 May 2020 | Kvartalsrapport 2020-Q1
19 May 2020 | Årsstämma 2019
20 May 2020 | Årligutdelning
25 Aug 2020 | Kvartalsrapport 2020-Q2
5 Nov 2020 | Kvartalsrapport 2020-Q3

ca.penser.se använder cookies för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder cookies. Vad är cookies?

Jag godkänner